{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:24:25Z","timestamp":1791606265295,"version":"4.3.4"},"reference-count":158,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Respiratory Medicine"],"published-print":{"date-parts":[[2026,6,3]]},"DOI":"10.1080\/17476348.2026.2615193","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:02:51Z","timestamp":1768820571000},"page":"693-711","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Recent updates on thymic stromal lymphopoietin as a therapeutic target for asthma"],"prefix":"10.1080","volume":"20","author":[{"given":"Ravneet K.","family":"Hansi","sequence":"first","affiliation":[{"name":"McMaster University","place":["Hamilton, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane E.","family":"Whetstone","sequence":"additional","affiliation":[{"name":"McMaster University","place":["Hamilton, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"Ranjbar","sequence":"additional","affiliation":[{"name":"McMaster University","place":["Hamilton, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Hassan","sequence":"additional","affiliation":[{"name":"McMaster University","place":["Hamilton, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail M.","family":"Gauvreau","sequence":"additional","affiliation":[{"name":"McMaster University","place":["Hamilton, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.271"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2731"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14165641"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8712-1"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2018.06.009"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102312"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2025.04.055"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0088-2024"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.117880"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00042-9"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31324-1"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S286036"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034975"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00735-y"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2008-0041OC"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2012.03.007"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep39559"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14937"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01595"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612725"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2020.1783242"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0210-8"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13357"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3675"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom14040401"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni805"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12435"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051135"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.1.336"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15609"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.8.2010002"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200307-1004OC"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2108015"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1159\/000072140"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092181"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.12.964"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119311"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00888"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.113759"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201506-377AW"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.09.007"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2024.16.1.1"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13985"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-13-11"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753465816632638"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.26.6.4757"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00826-2023"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13360"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105189"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.90376.2008"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2008.03151.x"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.06.011"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.11.915"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12050850"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2008.12.004"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03919.x"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000252"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902515"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep02301"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115398"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/01902148.2018.1536175"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.2926"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2019.1672657"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01526-6"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402895"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01513-x"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01296-2021"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704064"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2024.01.023"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S413064"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2414482"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00492-1"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00537-3"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.08.014"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A5231"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-025-03231-6"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.12.065"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-025-00714-4"},{"key":"e_1_3_5_82_1","unstructured":"A study to investigate GB-0895 in adults with Mild to moderate asthma or COPD [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07116889"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1400696"},{"key":"e_1_3_5_84_1","unstructured":"Study of MG-ZG122 humanized monoclonal antibody in asthma subjects [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07054034"},{"key":"e_1_3_5_85_1","unstructured":"A study to evaluate solriktug in adult Participants with asthma (RAINIER) [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06496607"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.6115"},{"key":"e_1_3_5_87_1","unstructured":"Study to evaluate the Safety pharmacology and efficacy of WIN378 in adults with moderate or severe asthma [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07120503"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tbae006"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113102"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2022.2082309"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01503-z"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S305114"},{"key":"e_1_3_5_93_1","unstructured":"A Phase 2 multi-centre Randomized Double-blind Placebo-controlled parallel group study to examine the effects of 24 weeks tezepelumab 210 mg sc q4wks on methacholine airway hyperresponsiveness in Participants with Mild allergic asthma 2023. [cited 2024 Sep 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05740748"},{"key":"e_1_3_5_94_1","unstructured":"Tezepelumab in the treatment of Co-morbid allergic rhinitis and allergic asthma study (TEZARS) - an Open-label exploratory mechanistic pilot study to evaluate tezepelumab efficacy in asthma and allergic rhinitis. 2024 [cited 2024 Sep 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06189742"},{"key":"e_1_3_5_95_1","first-page":"A1386","article-title":"Phase 1 Safety and efficacy of AZD8630\/AMG 104 inhaled anti-TSLP in Healthy volunteers and patients with asthma on medium-high dose inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) with elevated baseline fractional exhaled nitric oxide (FeNO) [Abstract]","volume":"209","author":"Doffman S","year":"2024","unstructured":"Doffman S, Dosanjh D, Sadiq MW, et al. Phase 1 Safety and efficacy of AZD8630\/AMG 104 inhaled anti-TSLP in Healthy volunteers and patients with asthma on medium-high dose inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) with elevated baseline fractional exhaled nitric oxide (FeNO) [Abstract]. Am J Respir Crit Care Med. 2024;209:A1386.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_5_96_1","unstructured":"A study to investigate the relative bioavailability of AZD8630 following a device and formulation transition in Healthy Participants 2025. Available from: https:\/\/www.astrazenecaclinicaltrials.com\/study\/D6830C00002\/"},{"key":"e_1_3_5_97_1","unstructured":"Safety A. Pharmacokinetic and pharmacodynamic study of Once daily inhaled AZD8630 in adults with asthma [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06795906"},{"key":"e_1_3_5_98_1","unstructured":"A dose range-Finding study to Assess the efficacy and Safety of multiple dose levels of AZD8630 in adults with uncontrolled asthma at risk of exacerbations (levante) [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06529419"},{"key":"e_1_3_5_99_1","unstructured":"A study of inhaled AZD8630 in adolescents with asthma (APkITA) [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07065331"},{"key":"e_1_3_5_100_1","unstructured":"A Phase I Randomized Double-Blind Placebo-Controlled study of TQC2731 Injection in Healthy adult subjects and patients with severe asthma. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT04923607"},{"key":"e_1_3_5_101_1","unstructured":"TQC2731 clinical trial for the treatment of severe asthma with Injection [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06829784"},{"key":"e_1_3_5_102_1","unstructured":"A study of CM326 in subjects with moderate to severe asthma [Internet]. 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05774340"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01193-2022"},{"key":"e_1_3_5_104_1","unstructured":"Study of Safety of CSJ117 in Participants with moderate to severe uncontrolled asthma [Internet]. 2022. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04946318"},{"key":"e_1_3_5_105_1","unstructured":"Study of efficacy and Safety of CSJ117 in patients with severe uncontrolled asthma [Internet]. 2024. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04410523"},{"key":"e_1_3_5_106_1","unstructured":"A trial of SHR-1905 in subjects with severe uncontrolled asthma [Internet]. 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05593250"},{"key":"e_1_3_5_107_1","unstructured":"A trial of SHR-1905 in subjects with severe uncontrolled asthma [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07098403"},{"key":"e_1_3_5_108_1","unstructured":"Pharmacokinetics Pharmacodynamics Safety and preliminary efficacy of Subcutaneous Injection of SHR-1905 in adolescent asthmatic subjects [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06786455"},{"key":"e_1_3_5_109_1","unstructured":"A dose Finding study with an anti-TSLP antibody (GSK5784283) in adults aged 18 to 75 years of age with uncontrolled asthma [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06748053"},{"key":"e_1_3_5_110_1","unstructured":"Single dose clinical trial of MG-ZG122 in Chinese Healthy adults subjects [Internet]. 2024. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05659927"},{"key":"e_1_3_5_111_1","unstructured":"A study to investigate efficacy and Safety of NSI-8226 in Healthy Participants [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06640920"},{"key":"e_1_3_5_112_1","unstructured":"A study to investigate Safety tolerability and Pharmacokinetics of Solrikitug in Healthy Japanese and non-Japanese Participants [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06868082"},{"key":"e_1_3_5_113_1","unstructured":"A trial of HBM9378 in Healthy Chinese subjects [Internet]. 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05790694"},{"key":"e_1_3_5_114_1","first-page":"A6996","article-title":"A multiple ascending-dose study with verekitug, a novel antibody to the human thymic stromal lymphopoietin receptor, in adults with asthma [Abstract]","volume":"209","author":"Singh D","year":"2024","unstructured":"Singh D, Deykin A, Lloyd P, et al. A multiple ascending-dose study with verekitug, a novel antibody to the human thymic stromal lymphopoietin receptor, in adults with asthma [Abstract]. Am J Respir Crit Care Med. 2024;209:A6996.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_5_115_1","unstructured":"A study to investigate the efficacy and Safety of verekitug (UPB-101) in adult Participants with severe asthma (VALIANT) [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06196879"},{"key":"e_1_3_5_116_1","unstructured":"A long-term Safety and efficacy study of verekitug (UPB-101) in adult Participants with severe asthma (VALOUR) [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06966479"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01461-2024"},{"key":"e_1_3_5_118_1","unstructured":"Dose ranging study of lunsekimig compared with Placbeo-controled in adult Participants with moderate-to-severe asthma (AIRCULES) [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06102005"},{"key":"e_1_3_5_119_1","unstructured":"Study of lunsekimig (SAR443765) compared with Placebo in adults with high-risk asthma (AIRLYMPUS) [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06676319"},{"key":"e_1_3_5_120_1","unstructured":"Long-term Safety and efficacy evaluation of lunsekimig (SAR443765) in adult Participants with moderate to severe asthma (AIRPHRODITE). 2025."},{"key":"e_1_3_5_121_1","unstructured":"A study to investigate the efficacy and Safety of Subcutaneous lusekimig (SAR443765) compared with Placebo in adult Participants with moderate to severe atopic dermatitis [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06790121"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.06.024"},{"key":"e_1_3_5_123_1","unstructured":"A Phase 1 study of CDX-622 [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06650761"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-024-00085-3"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2022.102184"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2024.OA3652"},{"key":"e_1_3_5_127_1","first-page":"A1378","article-title":"First-in-class inhalable anti-TSLP single domain antibody with therapeutic potential in asthma treatment [Abstract]","volume":"207","author":"Wan Y","year":"2023","unstructured":"Wan Y, Gai J, Zhu M, et al. First-in-class inhalable anti-TSLP single domain antibody with therapeutic potential in asthma treatment [Abstract]. Am J Respir Crit Care Med. 2023;207:A1378.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.16509"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-404717-4.00004-4"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00226-5"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2024.05.052"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1080\/15412555.2019.1708296"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1442588"},{"key":"e_1_3_5_134_1","unstructured":"Cambridge M Rotterdam NL Shanghai CN. Harbour BioMed announces license agreement with Windward Bio for HBM9378\/SKB378 an anti-TSLP fully human antibody for immunological diseases. 2025. Available from: https:\/\/www.harbourbiomed.com\/news\/231.html"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A1393"},{"key":"e_1_3_5_136_1","unstructured":"Aclaris therapeutics I. Aclaris therapeutics initiates Phase 1a\/1b program for its novel bispecific antibody ATI-052. 2025 Jun 23."},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adu3759"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.06.025"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16948"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.11.025"},{"key":"e_1_3_5_141_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019380"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17932"},{"key":"e_1_3_5_143_1","unstructured":"Savvides S Verstraete K Braun H et al. Novel tslp inhibitors. 2017. [cited 2025 Oct 5]. Available from: https:\/\/patents.google.com\/patent\/WO2017174556A1\/en"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2009-0418OC"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2021.152124"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2021-0301OC"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1627235"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081499"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cotox.2023.100420"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2024.05.009"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.971073"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2025.03.013"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.06.041"},{"key":"e_1_3_5_155_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2025.2517157"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.14879"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.05.033"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.3390\/genes14091721"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.18502\/ijaai.v19i4.4111"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2024.04.031"}],"container-title":["Expert Review of Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17476348.2026.2615193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:40:54Z","timestamp":1780306854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17476348.2026.2615193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":158,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,3]]}},"alternative-id":["10.1080\/17476348.2026.2615193"],"URL":"https:\/\/doi.org\/10.1080\/17476348.2026.2615193","relation":{},"ISSN":["1747-6348","1747-6356"],"issn-type":[{"value":"1747-6348","type":"print"},{"value":"1747-6356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierx20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierx20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}